Wen Xue
9PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 16, 2026
Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.Duo Xu, Yanyun Gao, Shengchen Liu
|Jul 29, 2025
Detecting Methylation Changes Induced by Prime Editing.Ronin Joshua S Cosiquien, Isaiah J Whalen, Phillip Wong
|Jul 24, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.Duo Xu, Yanyun Gao, Shengchen Liu
|Feb 10, 2025
Targeting ADAR1 with a small molecule for the treatment of prostate cancer.Xiao Wang, Jiaxing Li, Yasheng Zhu
|Dec 20, 2024
ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis.Zhongrui Shi, Jiaxing Li, Jiayu Ding
|May 20, 2024
AAV5 Delivery of CRISPR/Cas9 Mediates Genome Editing in the Lungs of Young Rhesus Monkeys.Shun-Qing Liang, Andrew W Navia, Michelle Ramseier
Pageof 2
Frequent Collaborators
2 joint publications
Haibin Deng
2 joint publications
Ralph A Schmid
2 joint publications
Wen Xue
2 joint publications
Erik J Sontheimer
2 joint publications
Duo Xu
2 joint publications
Yongqian Shu
2 joint publications
Ren-Wang Peng
2 joint publications
Peng Yang
2 joint publications
Xiao Wang
1 joint publications
Haiwei Mou
